Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $494.45M≈ (+$34M≈)
- Previous value:
- $460.36M≈
- # of changes:
- 45
- New positions:
- 6
- Reported for:
- 31 Mar 2025 (Q1)
- Latest filing date:
- 15 May 2025
Kahn Brothers Group has disclosed a total of 45 changes to the portfolio in the (2025 Q1) SEC report(s): increased the number of shares of 6, bought 6 totally new, decreased the number of shares of 30 and completely sold out 3 position(s).
What stocks did Kahn Brothers Group buy in 2025 Q1?
During 2025 Q1 Kahn Brothers Group has bought 12 securities out of which top 5 purchases (by % change to portfolio) were (FLG) Flagstar Financial, Inc (added shares +18.46%), (BAYRY) Bayer AG PK (added shares +45.88%), (OGN) Organon & Co (added shares +59.09%), (IDT) IDT Corp (added shares +53.02%) and (NVS) Novartis AG ADR (added shares +3.44%).
In the 2025 Q1 report(s) the following changes have been made to the top investments: (C) Citigroup Inc (reduced shares -3.31%), (FLG) Flagstar Financial, Inc (added shares +18.46%), (MRK) Merck & Company Inc (reduced shares -3.27%), (BAYRY) Bayer AG PK (added shares +45.88%) and (BP) BP PLC-SPONS ADR (reduced shares -3.53%).
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.